Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Tovey

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 11, 2014
Introduction: Lessons Learnt from the Use of Cytokines and Cytokine AntagonistsMichael G Tovey
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 15, 2010
Immunotherapy of multiple sclerosisMichael G Tovey
Taehan Kan Hakhoe Chi = the Korean Journal of Hepatology|December 25, 2002
Oromucosal cytokine therapy: mechanism(s) of actionMichael G Tovey
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Safety, Tolerability, and Immunogenicity of InterferonsMichael G Tovey, Christophe Lallemand
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2010
Adjuvant activity of cytokinesMichael G Tovey, Christophe Lallemand
Therapeutic Advances in Drug Safety|August 2, 2014
Immunogenicity and other problems associated with the use of biopharmaceuticalsMichael G Tovey, Christophe Lallemand
Bioanalysis|September 28, 2012
Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticalsMichael G Tovey, Christophe Lallemand
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2006
TL1A: a mediator of gut inflammationHoward A Young, Michael G Tovey
Journal of Leukocyte Biology|September 3, 2010
WHO international cytokine standards and reference preparationsMichael G Tovey, Meenu Wadhwa, Robin Thorpe
Biological Chemistry|October 28, 2008
Adjuvant activity of type I interferonsMichael G Tovey, Christophe Lallemand, George Thyphronitis
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 11, 2014
Introduction: Lessons Learnt from the Use of Cytokines and Cytokine AntagonistsMichael G Tovey
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 15, 2010
Immunotherapy of multiple sclerosisMichael G Tovey
Taehan Kan Hakhoe Chi = the Korean Journal of Hepatology|December 25, 2002
Oromucosal cytokine therapy: mechanism(s) of actionMichael G Tovey
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Safety, Tolerability, and Immunogenicity of InterferonsMichael G Tovey, Christophe Lallemand
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2010
Adjuvant activity of cytokinesMichael G Tovey, Christophe Lallemand
Therapeutic Advances in Drug Safety|August 2, 2014
Immunogenicity and other problems associated with the use of biopharmaceuticalsMichael G Tovey, Christophe Lallemand
Bioanalysis|September 28, 2012
Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticalsMichael G Tovey, Christophe Lallemand
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2006
TL1A: a mediator of gut inflammationHoward A Young, Michael G Tovey
Journal of Leukocyte Biology|September 3, 2010
WHO international cytokine standards and reference preparationsMichael G Tovey, Meenu Wadhwa, Robin Thorpe
Biological Chemistry|October 28, 2008
Adjuvant activity of type I interferonsMichael G Tovey, Christophe Lallemand, George Thyphronitis
Pageof 4